Loop is a DIY automated insulin delivery system with more customization and features than FDA-approved systems on the market. Justin Eastzer is a CNET Perspectives Contributor and former CNET host.

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the United States commercial launch of its new Tandem ...

New system combines Kaleido with Diabeloop’s DBLG2 algorithm and Dexcom G7, with first commercial deliveries in Germany and the Netherlands ...

Tandem Diabetes Care's t:slim X2 Insulin Pump Automated Insulin Delivery System is now the first to incorporate the Abbott FreeStyle Libre 2 Plus Sensor for users in the United States. The FreeStyle ...

Abbott’s latest innovation, the FreeStyle Libre® 2 Plus sensor, is available for the first time for t:slim X2™ insulin pump users in the U.S. Tandem’s Control-IQ™ hybrid closed-loop technology now ...

Please provide your email address to receive an email when new articles are posted on . The Control-IQ+ automated insulin delivery system was approved for use in pregnancy with the t:slim X2 and Mobi ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced U.S. Food and Drug Administration (FDA) clearance for ...

Young children using the t:slim X2 insulin pump with Control-IQ Technology system maintained target glucose levels for 3 hours longer than children using an insulin pump or daily injections with a ...

– Enhanced features extend automated insulin delivery (AID) to people ages 2 years and older with type 1 diabetes and adults with type 2 diabetes – Control-IQ+ automated insulin delivery technology ...

Significant advancements in diabetes management have marked the evolution of insulin delivery methods. Insulin was initially administered through injections, often leading to inconsistent blood ...

SAN DIEGO -- An automatic insulin delivery system bolstered type 1 diabetes outcomes even among users who didn't follow recommendations on boluses for meals and other corrections, according to a ...

Allowing patients to keep using their personal diabetes technology during hospitalization improves glycemic control and reduces length of stay.